Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
· ·
$7.21
▲ $0.14 (+2.0%)
Market data updated: 09/21 09:58 PM
Fundamentals updated: 09/21/2026
News analyzed: 09/21/2026
Market Cap
$88.58M
Day Range
$7.00 - $7.25
52-Week Range
$4.95 - $12.94
Beta
—
Next Earnings
04.11.2026
Support
$4.95
Resistance
$9.25
-41.8% (1Y)
Strengths: 6/28 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🔴 Bearish
Technical Trend
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Operating margin stability
Operating margin is stable or improving over time
Quality
Biggest negative driver
DCF Fair Value
Estimated fair value: -$27.85 vs. price $7.21 (-486.3%)
Fair Value
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
44
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
34
Quality
58
Value
38
Momentum
37
Risk
34
Sentiment
80
Fundamental
43
Institutional
No data available
Stocks with a similar DNA right now
Not enough comparably-scored stocks yet to show similar matches.
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of **LENSAR, Inc.** has centered on its **strong Q2 2026 financial performance**, highlighting record revenue growth and improved profitability. Analysts, including BTIG’s Ryan Zimmerman, maintained a **Buy rating** while raising their price target to **$10**, citing positive momentum. The company’s earnings call emphasized operational gains, though broader healthcare sector comparisons (e.g., Liminatus Pharma) were noted. Overall, LENSAR’s stock gained traction amid investor optimism.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about LENSAR, Inc.. News trend score: 80. Reason: 6 of the last 17 articles are positive, versus 1 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
24
🎯 Conviction (vs. Emotion)
39
Psychology
28
Fundamentals
43
Technical
37
Valuation
38
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
The price rise has far outpaced the actual improvement in fundamental data.
Price (3M)
+26%
Market Narrative
45
Fundamental Reality
39
Narrative Gap
+6
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market behavior suggests detached euphoria, where price remains significantly above long-term averages (43.9%) despite weak momentum (-1.6% ROC). This disconnect, combined with high positive sentiment (80/100), indicates investors may be ignoring recent underperformance. The narrative gap (15 points) further implies optimism exceeds tangible fundamentals. The key question is whether this optimism will sustain or if weak momentum will eventually reassert itself. FOMO remains muted, suggesting no urgent rush to buy, but euphoria’s persistence could delay a correction.
Updated: 09/07/2026, 05:28 PM
What could change this?
👥 What the crowd believes
"LENSAR reported a record revenue and profitability surge in Q2 2026 earnings call highlights"
"BTIG analyst Ryan Zimmerman maintains LENSAR with a Buy and raises price target from $7 to $9"
"Multiple sources (Motley Fool, GuruFocus, SeekingAlpha, Benzinga) publish Q2 2026 earnings call transcripts/summaries"
"LENSAR shares increased in Thursday’s intraday and pre-market sessions following earnings"
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 90/100
🔴 Weakest match
Morgan Housel — 0/100
🗣️ Why do they disagree?
This stock sparks a sharp divide among historical methodologies, with only a handful of investors seeing any potential while the majority flag it as risky or unclear. Burton Malkiel and John Bogle’s efficient-market approach leans cautiously mixed, suggesting the stock lacks a clear edge over passive indexing, while Jesse Livermore and Jack Schwager both see no decisive trend—implying either neutrality or a lack of conviction. Meanwhile, the more skeptical voices—like Gerald Loeb, Walter Bagehot, and Morgan Housel—paint a picture of volatility, poor liquidity, and emotional risk, scoring it near the bottom. Even growth-oriented investors like Fisher and Lynch dismiss it outright, while Benjamin Graham’s methods fail to find enough valuation or balance-sheet strength to justify a buy. The contrast highlights a stock that’s either too murky for disciplined investors or too volatile for patient ones.
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 90
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 82
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟢 78
Looks early-to-mid cycle, not overextended
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 52
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 48
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 45
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 45
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 36
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 35
Not enough valuation data for a real Enterprising-Graham read
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 20%
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 31
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 31
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 22
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🔴 19
Risk profile Loeb would flag as a real threat to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🔴 10
Not enough balance-sheet/valuation data for a real Graham read
Key question
Where is my margin of safety?
⚠️ Partial data for this stock — score is less reliable — Data availability: 15%
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🔴 8
Liquidity position Bagehot would flag as a real risk
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 0
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Based on the last 283 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (3 bullish · 8 bearish · 0 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
High confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
46.4%
Operating Margin
-42.1%
Net Margin
-58.7%
EBITDA Margin
-42.1%
ROE
131.7%
ROA
-48.0%
ROIC
—
EPS
-$2.87
Cash
$12.97M
Total Debt
—
Current Ratio
1.15
Debt/Equity
—
How is Fair Value calculated? →
Current Price
$7.21
Estimated Fair Value (DCF)
-$27.85
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
-486.3%
🔴 Appears expensive relative to estimated value
Year 1 Growth Rate
18.5%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 18.5% | $-17.67M | $-16.21M |
| 2 | 14.5% | $-20.22M | $-17.02M |
| 3 | 10.5% | $-22.34M | $-17.25M |
| 4 | 6.5% | $-23.79M | $-16.85M |
| 5 | 2.5% | $-24.38M | $-15.85M |
Base FCF (last actual year)
$-14.91M
Terminal Value
$-384.51M
Present Value of Terminal Value
$-249.91M
Enterprise Value
$-333.08M
Net Debt
$0
Equity Value
$-333.08M
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
-$2.18
Tangible Book Value per Share (Tangible NAV)
-$2.61
Sentiment based on basic keywords (not AI) — 6 positive, 10 neutral, 1 negative out of the last 17 articles.
Motley Fool · 20.8.2026
Benzinga · 20.8.2026
ChartMill · 14.8.2026
GuruFocus.com · 13.8.2026
MarketBeat · 13.8.2026
Moby · 13.8.2026
Benzinga · 13.8.2026
Benzinga · 13.8.2026
SeekingAlpha · 13.8.2026
GlobeNewswire · 13.8.2026
Benzinga · 13.8.2026
Benzinga · 13.8.2026
Benzinga · 13.8.2026
GuruFocus.com · 12.8.2026
GlobeNewswire · 6.8.2026
Zacks · 2.7.2026
Simply Wall St. · 4.6.2026
LENSAR, Inc. (LNSR) currently has a StockIQ AI score of 44/100, rated "Weak". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
LNSR currently scores 44/100 (Weak) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, LNSR's estimated fair value is -$27.85, which is 486.3% below the current price of $7.21. This is one valuation model among several signals in the fair-value category, not a price target.
LNSR's technical score is 37/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Operating margin is stable or improving over time; Return on equity (ROE): 131.7% — strong; Price is above the 50-day average.
Based on the real signals StockIQ computed: Estimated fair value: -$27.85 vs. price $7.21 (-486.3%); Operating margin: -42.1% (negative); Net margin: -58.7% (negative).
StockIQ has no recorded dividend payment history for LNSR.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 0 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| WEISNER AIMEE S | Grant/Award from Employer | 3.6.2026 | 17,421 | +17,421 | — |
| CURTIS NICHOLAS T | Grant/Award from Employer | 3.6.2026 | 130,662 | +130,662 | — |
| Connaughton Alan B. | Grant/Award from Employer | 3.6.2026 | 34,843 | +34,843 | — |
| ELLIS THOMAS B | Grant/Award from Employer | 3.6.2026 | 17,421 | +17,421 | — |
| LINK WILLIAM J PHD | Grant/Award from Employer | 3.6.2026 | 17,421 | +17,421 | — |
| LINDSTROM RICHARD L MD | Grant/Award from Employer | 3.6.2026 | 17,421 | +17,421 | — |
| O'Farrell Elizabeth G. | Grant/Award from Employer | 3.6.2026 | 17,421 | +17,421 | — |
| Winer Gary M | Grant/Award from Employer | 3.6.2026 | 17,421 | +17,421 | — |
| Wong Kendra | Grant/Award from Employer | 3.6.2026 | 13,066 | +13,066 | — |
| HAMMER TODD B | Grant/Award from Employer | 3.6.2026 | 17,421 | +17,421 | — |
| WEISNER AIMEE S | Grant/Award from Employer | 3.6.2026 | 110,368 | +17,421 | — |
| LINK WILLIAM J PHD | Grant/Award from Employer | 3.6.2026 | 568,062 | +17,421 | — |
| CURTIS NICHOLAS T | Grant/Award from Employer | 3.6.2026 | 1,122,758 | +130,662 | — |
| LINDSTROM RICHARD L MD | Grant/Award from Employer | 3.6.2026 | 263,831 | +17,421 | — |
| ELLIS THOMAS B | Grant/Award from Employer | 3.6.2026 | 56,083 | +17,421 | — |
| HAMMER TODD B | Grant/Award from Employer | 3.6.2026 | 56,083 | +17,421 | — |
| Winer Gary M | Grant/Award from Employer | 3.6.2026 | 105,635 | +17,421 | — |
| O'Farrell Elizabeth G. | Grant/Award from Employer | 3.6.2026 | 67,368 | +17,421 | — |
| Connaughton Alan B. | Grant/Award from Employer | 3.6.2026 | 389,173 | +34,843 | — |
| Wong Kendra | Grant/Award from Employer | 3.6.2026 | 56,481 | +13,066 | — |
| Connaughton Alan B. | Tax Withholding in Shares | 6.5.2026 | 2,739 | -2,739 | $5.39 |
| CURTIS NICHOLAS T | Other Transaction | 6.5.2026 | 0 | +0 | — |
| Wong Kendra | Tax Withholding in Shares | 6.5.2026 | 864 | -864 | $5.39 |
| STAAB THOMAS R II | Tax Withholding in Shares | 6.5.2026 | 1,350 | -1,350 | $5.39 |
| CURTIS NICHOLAS T | Other Transaction | 6.5.2026 | 992,096 | +0 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
381,943 shares short as of 2026-08-31 · vs. 451,087 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
31.3% of trading volume this week was short selling, vs. 18.4% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology